Status:
UNKNOWN
Results at 10 Years of the RESOLVE Study (RESOLVE+10)
Lead Sponsor:
University Hospital, Clermont-Ferrand
Collaborating Sponsors:
University Hospital CHU Clermont-Ferrand, 58 rue Montalembert 63003 Clermont-Ferrand, France
Université d'Auvergne
Conditions:
Metabolic Syndrome
Eligibility:
All Genders
50-70 years
Phase:
NA
Brief Summary
10-year effect of a lifestyle intervention program (exercise, sedentary lifestyle and dietary diet) on abdominal visceral adipose tissue (primary endpoint of the RESOLVE study 10 years ago): influence...
Detailed Description
The RESOLVE + 10 protocol was design to provide a 10-year effect of a lifestyle intervention program (exercise, sedentary lifestyle and dietary diet) on abdominal visceral adipose tissue. In the pres...
Eligibility Criteria
Inclusion
- patients and healthy controls included in the RESOLVE study
Exclusion
- refusal of participation
Key Trial Info
Start Date :
September 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2021
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT04453098
Start Date
September 1 2020
End Date
July 1 2021
Last Update
July 1 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU de Clermont-Ferrand
Clermont-Ferrand, France, 63000